Market Capitalization Changement Date
AbbVie USD 313.64B 40.03B 2024-03
Acorda Therapeutics USD 16M 2M 2023-06
Agios Pharmaceuticals USD 1.68B 434M 2024-03
ALKERMES USD 4.63B 36M 2023-12
Alnylam Pharmaceuticals USD 18.47B 5.56B 2024-03
Amgen USD 148.35B 5.79B 2024-03
Biogen USD 31.4B 6.09B 2024-03
BioMarin Pharmaceutical USD 15.87B 2.29B 2024-03
Bluebird Bio USD 325M 25M 2023-09
Bristol-Myers Squibb USD 105.66B 1.26B 2024-03
Eli Lilly USD 731.69B 178.32B 2024-03
Gilead Sciences USD 90.93B 10.01B 2024-03
GlaxoSmithKline GBP 59.68B 1.42B 2023-12
Incyte USD 12.89B 1.18B 2024-03
J&J USD 375.41B 1.91B 2024-03
Merck USD 314.33B 38.07B 2024-03
Moderna USD 40.08B 2.16B 2024-03
Neurocrine Biosciences USD 14.28B 1.33B 2024-03
Novartis CHF 193.29B 20.5B 2023-12
Pfizer USD 155.51B 7.05B 2024-03
PTC Therapeutics USD 2.22B 145M 2024-03
Regeneron Pharmaceuticals USD 106.74B 11.05B 2024-03
Sanofi EUR 113.53B 14.8B 2023-12
Sarepta Therapeutics USD 11.76B 2.73B 2024-03
United Therapeutics USD 11.05B 721M 2024-03
Vertex Pharmaceuticals USD 106.53B 1.68B 2024-03



Gilead Sciences Capitalisation Boursière - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.